Temozolomide: A new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours
- 1 January 1993
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (7) , 940-942
- https://doi.org/10.1016/s0959-8049(05)80198-4
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856)British Journal of Cancer, 1992
- Response criteria for phase II studies of supratentorial malignant glioma.Journal of Clinical Oncology, 1990
- Studies on high grade cerebral gliomasInternational Journal of Radiation Oncology*Biology*Physics, 1990
- The role of chemotherapy in the treatment of gliomas in adultsCancer Treatment Reviews, 1989
- A randomized study of CCNU with and without benznidazole in the treatment of recurrent grades 3 and 4 astrocytoma: Report to the Medical Research Council by the Brain Tumor Working PartyInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Effect of HECNU in malignant supratentorial gliomas ? a phase II studyJournal of Neuro-Oncology, 1988
- Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomasJournal of Neurosurgery, 1978